Jun 06, 2019
Regulatory Affairs for Pharmaceutical Support Staff: Overview of EU Regulatory (Regulations, Directives and Guidelines) Procedures - London, United Kingdom - September 23-24, 2019
Jun 03, 2019
Two Day UK Seminar: Pharmaceutical Regulatory Affairs for Support Staff - Gain an Overview of EU Regulatory Procedures (London, United Kingdom - September 23-24, 2019)
May 28, 2019
Global Orphan Drugs (Biologics, and Non-Biologics) Markets, 2016-2019 & 2024 - Select Product Approvals/Launches, Recent Industry Activity, & Focus on Key Players
Apr 29, 2019
Titan Pharmaceuticals And Molteni Announce Positive EU CHMP Opinion For Probuphine®
Apr 09, 2019
Soligenix and the European Medicines Agency Pediatric Committee Reach Agreement on the Pediatric Investigation Plan for SGX942
Apr 01, 2019
Heron Announces European Medicines Agency Validation of Marketing Authorisation Application for HTX-011 for Postoperative Pain Management
Apr 01, 2019
OncoSec Announces Advanced Therapy Medicinal Product Classification from the EMA for TAVO(TM) in Refractory Metastatic Melanoma
Mar 21, 2019
Stacey Ma, Ph.D. Joins Sana Biotechnology as Executive Vice President, Technical Operations
Mar 05, 2019
MYR Pharma Announces Grant of Promising Innovative Medicine (PIM) Designation by British MHRA for Bulevirtide (Myrcludex), the First-in-Class Entry Inhibitor for Treatment of Chronic Hepatitis D Infections
Mar 01, 2019
Hansa Biopharma Announces European Medicines Agency Accepts Marketing Authorization Application for IDEFIRIX(TM) (imlifidase)
Feb 04, 2019
FDAnews Announces -- Biosimilars Regulation: Latest Regulatory, Compliance & Approval Developments Webinar, Feb. 14, 2019
Jan 29, 2019
Global Orphan Drugs Industry
Jan 07, 2019
Rexgenero's Lead Product REX-001 Selected for the EUnetHTA Prioritisation List for Joint Assessments
Nov 26, 2018
CTI BioPharma Provides Program Update Following Regulatory Feedback on Pacritinib Development from the European Medicines Agency
Nov 13, 2018
Modis Therapeutics Announces PRIME Designation Granted by the European Medicines Agency to MT1621 for the Treatment of TK2 Deficiency
Nov 06, 2018
FDAnews Announces: Early Bird Pricing Ends on Nov. 13 for ICH E6 GCP Interactive Workshops, Dec. 11-12, 2018
Oct 30, 2018
Blueprint Medicines Reports Third Quarter 2018 Financial Results
Oct 09, 2018
FDAnews Announces: ICH E6 GCP Interactive Workshop: How to Build a Sponsor Risk Management Program, Dec. 11-12, 2018
Aug 09, 2018
JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer
Jul 10, 2018
BPSA's Barcelona Summit to Focus on Innovation, Next-Generation Opportunities in Single-Use Processing, Cell Therapies